| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
0.858 |
Evidence |
|
| TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
CNN3 |
CNN3: Calponin-3 |
0.858 |
Evidence |
|
| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.858 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
0.858 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
GP5 |
GP5: Platelet glycoprotein V precursor |
0.858 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.858 |
Evidence |
|
| LOX |
LOX: Protein-lysine 6-oxidase precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
0.858 |
Evidence |
|
| CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
0.858 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.858 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
C6 |
C6: Complement component C6 precursor |
0.858 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
SNCB |
SNCB: Beta-synuclein |
0.858 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
CCNB1 |
Cyclin B1 |
0.858 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
0.858 |
Evidence |
|
| GP9 |
GP9: Platelet glycoprotein IX precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.858 |
Evidence |
|
| GP9 |
GP9: Platelet glycoprotein IX precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.858 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
ALB |
ALB: Uncharacterized protein ALB |
0.858 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.858 |
Evidence |
|
| NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
0.858 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.858 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
GP5 |
GP5: Platelet glycoprotein V precursor |
0.858 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.858 |
Evidence |
|
| RRAS |
RRAS: Ras-related protein R-Ras precursor |
CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
0.858 |
Evidence |
|
| PAEP |
PAEP: Glycodelin precursor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.858 |
Evidence |
|
| ELA3B |
ELA3B: Elastase-3B precursor |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
0.858 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
NAGPA |
NAGPA: N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase precur |
0.858 |
Evidence |
|